KIF9 and hepatocellular carcinoma: As an m6A-modified lncRNA, KIF9–AS1 promotes the stem cell properties and sorafenib resistance of HCC by promoting USP1-mediated deubiquitination of short stature homeobox 2 (SHOX2).